Milestone Scientific (NYSE:MLSS) Now Covered by Analysts at StockNews.com

StockNews.com assumed coverage on shares of Milestone Scientific (NYSE:MLSS) in a research note published on Thursday. The firm issued a hold rating on the stock.

Milestone Scientific Trading Down 6.6 %

Shares of MLSS opened at $0.65 on Thursday. Milestone Scientific has a 52 week low of $0.52 and a 52 week high of $1.35. The firm has a market cap of $49.79 million, a price-to-earnings ratio of -6.50 and a beta of 0.94. The stock has a 50 day moving average of $0.65 and a 200-day moving average of $0.69.

Milestone Scientific (NYSE:MLSS) last released its quarterly earnings data on Friday, March 29th. The company reported ($0.03) EPS for the quarter. Milestone Scientific had a negative return on equity of 86.72% and a negative net margin of 70.50%. The business had revenue of $2.26 million during the quarter.

Hedge Funds Weigh In On Milestone Scientific

An institutional investor recently bought a new position in Milestone Scientific stock. AE Wealth Management LLC acquired a new stake in shares of Milestone Scientific Inc. (NYSE:MLSS) in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 27,936 shares of the company’s stock, valued at approximately $26,000. 5.79% of the stock is owned by institutional investors.

About Milestone Scientific

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.